Literature DB >> 27272650

Left ventricular performance during triggered left ventricular pacing in patients with cardiac resynchronization therapy and left bundle branch block.

Christoffer Tobias Witt1, Mads Brix Kronborg2, Ellen Aagaard Nohr3, Jens Cosedis Nielsen2.   

Abstract

PURPOSE: To assess the acute effect of triggered left ventricular pacing (tLVp) on left ventricular performance and contraction pattern in patients with heart failure, left bundle branch block (LBBB), and cardiac resynchronization therapy (CRT).
METHODS: Twenty-three patients with pre-implant QRS complex >150 ms, QRS complex narrowing under CRT, and sinus rhythm were included ≥3 months after CRT implantation. Echocardiographic assessment of left ventricular ejection fraction (LVEF), global peak systolic longitudinal strain (GLS), and contraction pattern by 2D strain was performed during intrinsic conduction, tLVp, and BiV pacing and compared as paired data. Echocardiographic analysis was done blinded with respect to pacing mode.
RESULTS: LVEF was significantly higher during BiV pacing (47 ± 11 %) compared with intrinsic conduction (43 ± 13 %, P = 0.001) and tLVp (44 ± 13 %, P = 0.001), while there was no difference between intrinsic conduction and tLVp (P = 0.28). GLS was higher during BiV (14 ± 3) than during intrinsic conduction (13 ± 3, P = 0.01) and tLVp (13 ± 3, P = 0.03). Difference in time-to-peak contraction between the basal septal and lateral walls was shorter during BiV pacing (-3 ± 44 ms) than during intrinsic conduction (129 ± 66, P < 0.001) and tLVp (118 ± 118 ms, P < 0.001), with no difference between tLVp and intrinsic conduction (P = 0.56). The electrocardiogram showed change in frontal axis from intrinsic conduction in only 2 (9 %) patients during tLVp and in 20 (87 %) patients during BiV pacing.
CONCLUSIONS: The acute effect of tLVp on LV systolic function and contraction pattern is significantly lower than the effect of BiV pacing and not different from intrinsic conduction in patients with LBBB and CRT.

Entities:  

Keywords:  Cardiac resynchronization therapy; Echocardiography; Speckle tracking; Triggered left ventricular pacing

Mesh:

Year:  2016        PMID: 27272650     DOI: 10.1007/s10840-016-0155-0

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  19 in total

1.  2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).

Authors:  Michele Brignole; Angelo Auricchio; Gonzalo Baron-Esquivias; Pierre Bordachar; Giuseppe Boriani; Ole-A Breithardt; John Cleland; Jean-Claude Deharo; Victoria Delgado; Perry M Elliott; Bulent Gorenek; Carsten W Israel; Christophe Leclercq; Cecilia Linde; Lluís Mont; Luigi Padeletti; Richard Sutton; Panos E Vardas
Journal:  Europace       Date:  2013-06-24       Impact factor: 5.214

2.  Variability of global left ventricular deformation analysis using vendor dependent and independent two-dimensional speckle-tracking software in adults.

Authors:  Niels Risum; Sophia Ali; Niels T Olsen; Christian Jons; Michel G Khouri; Trine K Lauridsen; Zainab Samad; Eric J Velazquez; Peter Sogaard; Joseph Kisslo
Journal:  J Am Soc Echocardiogr       Date:  2012-09-12       Impact factor: 5.251

3.  Early detection of atrial high rate episodes predicts atrial fibrillation and thromboembolic events in patients with cardiac resynchronization therapy.

Authors:  Christoffer Tobias Witt; Mads Brix Kronborg; Ellen Aagaard Nohr; Peter Thomas Mortensen; Christian Gerdes; Jens Cosedis Nielsen
Journal:  Heart Rhythm       Date:  2015-07-08       Impact factor: 6.343

Review 4.  Ventricular resynchronization is the principle mechanism of benefit with cardiac resynchronization therapy.

Authors:  John Gorcsan; Cheuk-Man Yu; John E Sanderson
Journal:  Heart Fail Rev       Date:  2012-11       Impact factor: 4.214

5.  Meta-analysis of randomized controlled trials evaluating left ventricular vs. biventricular pacing in heart failure: effect on all-cause mortality and hospitalizations.

Authors:  Giuseppe Boriani; Beatrice Gardini; Igor Diemberger; Maria Letizia Bacchi Reggiani; Mauro Biffi; Cristian Martignani; Matteo Ziacchi; Cinzia Valzania; Maurizio Gasparini; Luigi Padeletti; Angelo Branzi
Journal:  Eur J Heart Fail       Date:  2012-04-17       Impact factor: 15.534

6.  The utility of 12-lead Holter monitoring in patients with permanent atrial fibrillation for the identification of nonresponders after cardiac resynchronization therapy.

Authors:  Ganesh S Kamath; Delia Cotiga; Jayanthi N Koneru; Aysha Arshad; Walter Pierce; Emad F Aziz; Anisha Mandava; Suneet Mittal; Jonathan S Steinberg
Journal:  J Am Coll Cardiol       Date:  2009-03-24       Impact factor: 24.094

7.  Effect of optimizing the VV interval on left ventricular contractility in cardiac resynchronization therapy.

Authors:  Berry M van Gelder; Frank A Bracke; Albert Meijer; Lex J M Lakerveld; Nico H J Pijls
Journal:  Am J Cardiol       Date:  2004-06-15       Impact factor: 2.778

8.  Effect of biventricular pacing during a ventricular sensed event.

Authors:  Mehmet Kemal Aktas; Vinodh Jeevanantham; Saadia Sherazi; Dennis Flynn; Burr Hall; David T Huang; Spencer Rosero; James P Daubert; Abrar H Shah
Journal:  Am J Cardiol       Date:  2009-05-04       Impact factor: 2.778

9.  Variable patterns of septal activation in patients with left bundle branch block and heart failure.

Authors:  Luz-Maria Rodriguez; Carl Timmermans; Ashish Nabar; Graydon Beatty; Hein J J Wellens
Journal:  J Cardiovasc Electrophysiol       Date:  2003-02

10.  Atrial fibrillation is under-recognized in chronic heart failure: insights from a heart failure cohort treated with cardiac resynchronization therapy.

Authors:  Jane C Caldwell; Hussain Contractor; Sanjiv Petkar; Razwan Ali; Bernard Clarke; Clifford J Garratt; Ludwig Neyses; Mamas A Mamas
Journal:  Europace       Date:  2009-08-01       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.